Noevir Holdings Co (TSE:4928) Debt-to-EBITDA : 0.06 (As of Mar. 2026) — 40% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4928 Noevir Holdings Co Ltd TSE:4928
89 GF Score
Price 円4,875.00
GF Value 円4,976.45
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Noevir Holdings Co Debt-to-EBITDA?

Noevir Holdings Co TSE:4928 +0.10% 89 Debt-to-EBITDA is 0.06 as of Mar. 2026, which is 40% below its 10-year median of 0.10. GuruFocus rates TSE:4928 with a GF Score™ of 89/100 and a GF Value™ of 円4,976.45 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,559 Consumer Packaged Goods companies, Noevir Holdings Co ranks better than 94.93% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Noevir Holdings Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was 円83 Mil. Noevir Holdings Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was 円616 Mil. Noevir Holdings Co's annualized EBITDA for the quarter that ended in Mar. 2026 was 円11,096 Mil. Noevir Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 was 0.06.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Noevir Holdings Co's Debt-to-EBITDA or its related term are showing as below:

TSE:4928' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.06   Med: 0.1   Max: 0.18
Current: 0.06

During the past 13 years, the highest Debt-to-EBITDA Ratio of Noevir Holdings Co was 0.18. The lowest was 0.06. And the median was 0.10.

TSE:4928's Debt-to-EBITDA is ranked better than
94.93% of 1559 companies
in the Consumer Packaged Goods industry
Industry Median: 2.12 vs TSE:4928: 0.06

Noevir Holdings Co  (TSE:4928) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Noevir Holdings Co Debt-to-EBITDA Related Terms


Noevir Holdings Co Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Noevir Holdings Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noevir Holdings Co Debt-to-EBITDA Chart

Noevir Holdings Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.09 0.08 0.07 0.06

Noevir Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.08 0.06 0.08 0.06

TSE:4928 vs PG, CL, KVUE: Debt-to-EBITDA Comparison

For the Household & Personal Products subindustry, Noevir Holdings Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Noevir Holdings Co Debt-to-EBITDA vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Noevir Holdings Co's Debt-to-EBITDA falls into.


TSE:4928
89GF Score
Noevir Holdings Co Ltd TSE:4928
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Noevir Holdings Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Noevir Holdings Co's Debt-to-EBITDA for the fiscal year that ended in Sep. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(85 + 657) / 11943
=0.06

Noevir Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(83 + 616) / 11096
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of 0.06 mean?
Noevir Holdings Co (TSE:4928) has a Debt-to-EBITDA of 0.06 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Noevir Holdings Co. This is 40% below median its historical median of 0.10. Over the past decade, Noevir Holdings Co's Debt-to-EBITDA has ranged from 0.06 to 0.18. According to the industry distribution chart, Noevir Holdings Co ranks #79 out of 1559 companies in the Consumer Packaged Goods industry, placing it in the top 5.1%.
Is Noevir Holdings Co's Debt-to-EBITDA too high?
Noevir Holdings Co's current Debt-to-EBITDA of 0.06 is 40% below median its 10-year median of 0.10. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 0.18. The Consumer Packaged Goods industry median Debt-to-EBITDA is 2.12. Noevir Holdings Co's value of 0.06 is 97.2% below this industry median. Based on the distribution chart, Noevir Holdings Co ranks #79 out of 1559 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Noevir Holdings Co has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Noevir Holdings Co's Debt-to-EBITDA compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Noevir Holdings Co ranks #79 out of 1559 companies for Debt-to-EBITDA. This places Noevir Holdings Co in the top 5% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.12. Noevir Holdings Co's value of 0.06 is 97.2% below this benchmark. Historically, Noevir Holdings Co's own Debt-to-EBITDA has ranged from 0.06 to 0.18 over the past decade. While the company's 10-year median is 0.10 vs. the industry median of 2.12, Noevir Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Consumer Packaged Goods company?
The median Debt-to-EBITDA among Consumer Packaged Goods companies is 2.12, based on 1,559 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Noevir Holdings Co's current Debt-to-EBITDA of 0.06 is 97.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Noevir Holdings Co. For the Consumer Packaged Goods industry, the median Debt-to-EBITDA is 2.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Noevir Holdings Co's current Debt-to-EBITDA is 0.06, which is 40% below median its own 10-year median of 0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noevir Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Noevir Holdings Co (TSE:4928) is currently considered Fairly Valued. The stock's GF Value™ is 円4,976.45, compared to a current price of 円4,875.00 — trading 2% below its estimated fair value. The current Debt-to-EBITDA is 0.06, which is 40% below median its 10-year median of 0.10 and 97.2% below the Consumer Packaged Goods industry median of 2.12. Noevir Holdings Co's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Noevir Holdings Co (TSE:4928), the current Debt-to-EBITDA is 0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?

Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued. The current stock price of 円4,875.00 is trading 2% below its estimated GF Value™ of 円4,976.45. GuruFocus considers Noevir Holdings Co to be Fairly Valued.

Key valuation signals for TSE:4928:

  • Debt-to-EBITDA: 0.06 (40% below median its 10-year median of 0.10)
  • GF Value™: 円4,976.45 vs. price of 円4,875.00 (2% below fair value)
  • GF Score™: 89/100 with 2 warning signs
  • Industry Position: 97.2% below the Consumer Packaged Goods median (#79 of 1559)

No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Noevir Holdings Co Business Description

Address 13-1, Minatojima Nakamachi 6-chome, Chuo-ku, Kobe, JPN, 650-8521
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
89GF Score

Get the complete analysis for TSE:4928

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,875.00
Price
円4,976.45
GF Value